James A. Popp

6.1k total citations · 1 hit paper
104 papers, 4.9k citations indexed

About

James A. Popp is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, James A. Popp has authored 104 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 26 papers in Cancer Research and 25 papers in Oncology. Recurrent topics in James A. Popp's work include Carcinogens and Genotoxicity Assessment (23 papers), Peroxisome Proliferator-Activated Receptors (20 papers) and Drug Transport and Resistance Mechanisms (20 papers). James A. Popp is often cited by papers focused on Carcinogens and Genotoxicity Assessment (23 papers), Peroxisome Proliferator-Activated Receptors (20 papers) and Drug Transport and Resistance Mechanisms (20 papers). James A. Popp collaborates with scholars based in United States, United Kingdom and Switzerland. James A. Popp's co-authors include Daniel S. Marsman, Russell C. Cattley, James S. Bus, James G. Conway, Robert O. Beauchamp, Craig J. Boreiko, Dragana A. Andjelkovich, Thomas L. Goldsworthy, Byron E. Butterworth and James A. Swenberg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JNCI Journal of the National Cancer Institute and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

James A. Popp

103 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Critical Review of the Literature on Hydrogen Sulfide Toxicity

1984 840 citations James A. Popp et al. profile →

Peers

Countries citing papers authored by James A. Popp

Since Specialization

Citations

This map shows the geographic impact of James A. Popp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Popp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Popp more than expected).

Fields of papers citing papers by James A. Popp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James A. Popp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Popp. The network helps show where James A. Popp may publish in the future.

Co-authorship network of co-authors of James A. Popp

This figure shows the co-authorship network connecting the top 25 collaborators of James A. Popp. A scholar is included among the top collaborators of James A. Popp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James A. Popp. James A. Popp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	4.6 - Partikel- und chipbasierte Anreicherung von Bakterien für einen Point-of-Care-Nachweis 2017 ·Tagungsband ·Karl Weber, (unknown), (unknown), James A. Popp	1
2	Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPAR α ) as a case study 2013 ·Critical Reviews in Toxicology ·J. Christopher Corton, Michael L. Cunningham, B. Timothy Hummer, Christopher Lau, Bette Meek, Jeffrey M. Peters, James A. Popp, Lorenz R. Rhomberg, Jennifer Seed, James E. Klaunig	181
3	Optimizing of isolation, purification and function of islets from the pancreas of the adult large German pig 1997 ·Transplantation Proceedings ·Andreas Schwarz, Min Kyu Jung, P. F. Heeckt, (unknown), James A. Popp, A Nüssler, Bernhard Böhm, H. G. Beger	3
4	The Peroxisome Proliferators WY-14,643 and Methylclofenapate Induce Hepatocyte Ploidy Alterations and Ploidy-Specific DNA Synthesis in F344 Rats 1996 ·Toxicology and Applied Pharmacology ·Richard T. Miller, (unknown), (unknown), James A. Popp	15
5	Effect of the Hepatocarcinogenic Peroxisome Proliferator Wy-14,643 in Vivo: No Increase in Ethane Exhalation or Hepatic Conjugated Dienes 1995 ·Toxicology and Applied Pharmacology ·James G. Conway, James A. Popp	11
6	TGFα is differentially expressed in liver foci induced by diethylnitrosamine initiation and peroxisome proliferator promotion 1995 ·Carcinogenesis ·Richard T. Miller, Russell C. Cattley, Daniel S. Marsman, Otis Lyght, James A. Popp	27
7	Retrospective assessment of liver cell proliferation via PCNA: a comparison with tritiated thymidine 1994 ·Cancer Letters ·Daniel R. Dietrich, (unknown), Daniel S. Marsman, James A. Popp, William K. Kaufmann, James A. Swenberg	12
8	Lack of Comitogenicity by the Peroxisome Proliferator Hepatocarcinogens, Wy-14,643 and Clofibric Acid 1993 ·Toxicology and Applied Pharmacology ·Daniel S. Marsman, (unknown), James A. Popp	19
9	Contrasting hepatocytic peroxisome proliferation, lipofuscin accumulation and cell turnover for the hepatocarcinogens Wy-14,643 and clofibric acid 1992 ·Carcinogenesis ·Daniel S. Marsman, Thomas L. Goldsworthy, James A. Popp	62
10	Mitogenic stimulation of hepatocellular proliferation in rodents following 1,4-dichlorobenzene administration 1992 ·Carcinogenesis ·Sandra R. Eldridge, Thomas L. Goldsworthy, James A. Popp, Byron E. Butterworth	59
11	Several nongenotoxic carcinogens uncouple mitochondrial oxidative phosphorylation 1992 ·Biochimica et Biophysica Acta (BBA) - Bioenergetics ·Barbara Keller, Daniel S. Marsman, James A. Popp, Ronald G. Thurman	43
12	Promotion of hepatocellular foci in female rats by chenodeoxycholic acid 1991 ·Carcinogenesis ·Patricia Blair, James A. Popp, (unknown), M.B. Thompson	9
13	Age-related susceptibility to the carcinogenic effect of the peroxisome proliferator WY-14,643 in rat liver 1991 ·Carcinogenesis ·Russell C. Cattley, Daniel S. Marsman, James A. Popp	70
14	Possible Mechanisms in Hepatocarcinogensis by the Peroxisome Proliferator Di(2-Ethylhexyl)Phthalate 1989 ·Drug Metabolism Reviews ·James G. Conway, Russell C. Cattley, James A. Popp, Byron E. Butterworth	59
15	Failure of the peroxisome proliferator WY-14,643 to initiate growth-selectible foci in rat liver 1989 ·Toxicology ·Russell C. Cattley, Daniel S. Marsman, James A. Popp	31
16	Failure of the peroxisome proliferator WY-14,643 to induce unscheduled DNA synthesis in rat hepatocytes following in vivo treatment 1988 ·Carcinogenesis ·Russell C. Cattley, Tracey Smith-Oliver, Byron E. Butterworth, James A. Popp	31
17	Trypan blue uptake as a new method to investigate hepatotoxicity in periportal and pericentral regions of the liver lobule: studies with allyl alcohol in the perfused liver. 1984 ·Journal of Pharmacology and Experimental Therapeutics ·Steven A. Belinsky, James A. Popp, F C Kauffman, Ronald G. Thurman	67
18	Comparative Toxicity of Feeding Dried Urban Sludge and an Equivalent Amount of Cadmium to Swine 1981 ·American Journal of Veterinary Research ·(unknown), G. T. Edds, James A. Popp	4
19	Poxlike Skin Lesions in Captive Caimans 1979 ·Journal of the American Veterinary Medical Association ·Elliott R. Jacobson, James A. Popp, R.P. Shields, Jack Μ. Gaskin	3
20	Meningoencephalitis Secondary to Otitis in a Gorilla 1978 ·Journal of the American Veterinary Medical Association ·(unknown), James A. Popp	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact